Anocca Submits Trial Application for VIDAR-1 in Pancreatic Cancer
26 Nov 2024 //
GLOBENEWSWIRE
Anocca Presents TCR-T Cell Therapy Data At ESMO Congress
09 Sep 2024 //
GLOBENEWSWIRE
Anocca And Shinobi Partner On Allogeneic TCR-T Cell Therapies
30 May 2024 //
GLOBENEWSWIRE
Anocca AB Licenses Gene Editing Technology from EmendoBio Inc.
14 Mar 2024 //
GLOBENEWSWIRE
Anocca Appoints Martin Welschof to Board of Directors
13 Feb 2024 //
GLOBENEWSWIRE
Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies
04 Jan 2024 //
GLOBENEWSWIRE
Anocca raises SEK 400 m for large-scale development of cancer cell therapies
31 May 2023 //
GLOBENEWSWIRE